These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 10880395)

  • 1. Recurrent genetic aberrations in thymoma and thymic carcinoma.
    Zettl A; Ströbel P; Wagner K; Katzenberger T; Ott G; Rosenwald A; Peters K; Krein A; Semik M; Müller-Hermelink HK; Marx A
    Am J Pathol; 2000 Jul; 157(1):257-66. PubMed ID: 10880395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clusters of chromosomal imbalances in thymic epithelial tumours are associated with the WHO classification and the staging system according to Masaoka.
    Penzel R; Hoegel J; Schmitz W; Blaeker H; Morresi-Hauf A; Aulmann S; Hecker E; Mechtersheimer G; Otto HF; Rieker RJ
    Int J Cancer; 2003 Jul; 105(4):494-8. PubMed ID: 12712440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosomal imbalances in carcinoma showing thymus-like elements (CASTLE).
    Veits L; Mechtersheimer G; Steger C; Freitag J; Mikuz G; Schmid KW; Hofmann W; Schirmacher P; Hartmann A; Rieker RJ
    Virchows Arch; 2011 Aug; 459(2):221-6. PubMed ID: 21735166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlating genetic aberrations with World Health Organization-defined histology and stage across the spectrum of thymomas.
    Inoue M; Starostik P; Zettl A; Ströbel P; Schwarz S; Scaravilli F; Henry K; Willcox N; Müller-Hermelink HK; Marx A
    Cancer Res; 2003 Jul; 63(13):3708-15. PubMed ID: 12839963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation of amplification of chromosome 1 with histologic typing of thymic epithelial tumors].
    Ma YQ; Zhang C; Cui WL; Gulinaer A; Zhang W; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):820-4. PubMed ID: 22336207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Profiling of Thymoma and Thymic Carcinoma: Genetic Differences and Potential Novel Therapeutic Targets.
    Enkner F; Pichlhöfer B; Zaharie AT; Krunic M; Holper TM; Janik S; Moser B; Schlangen K; Neudert B; Walter K; Migschitz B; Müllauer L
    Pathol Oncol Res; 2017 Jul; 23(3):551-564. PubMed ID: 27844328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metastatic type A thymoma: morphological and genetic correlation.
    Bürger T; Schaefer IM; Küffer S; Bohnenberger H; Reuter-Jessen K; Chan JK; Emmert A; Hinterthaner M; Marx A; Ströbel P
    Histopathology; 2017 Apr; 70(5):704-710. PubMed ID: 27926794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas.
    Girard N; Shen R; Guo T; Zakowski MF; Heguy A; Riely GJ; Huang J; Lau C; Lash AE; Ladanyi M; Viale A; Antonescu CR; Travis WD; Rusch VW; Kris MG; Pao W
    Clin Cancer Res; 2009 Nov; 15(22):6790-9. PubMed ID: 19861435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical differentiation between type B3 thymomas and thymic squamous cell carcinomas.
    Su XY; Wang WY; Li JN; Liao DY; Wu WL; Li GD
    Int J Clin Exp Pathol; 2015; 8(5):5354-62. PubMed ID: 26191237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CALML5 is a novel diagnostic marker for differentiating thymic squamous cell carcinoma from type B3 thymoma.
    Kanamori K; Suina K; Shukuya T; Takahashi F; Hayashi T; Hara K; Saito T; Mitsuishi Y; Shimamura SS; Winardi W; Tajima K; Ko R; Mimori T; Asao T; Itoh M; Kawaji H; Suehara Y; Takamochi K; Suzuki K; Takahashi K
    Thorac Cancer; 2023 Apr; 14(12):1089-1097. PubMed ID: 36924358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinicopathological significance of thymic epithelial markers expression in thymoma and thymic carcinoma.
    Li H; Ren B; Yu S; Gao H; Sun PL
    BMC Cancer; 2023 Feb; 23(1):161. PubMed ID: 36797681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Familial thymoma].
    Wuketich S; Zwintz E
    Wien Klin Wochenschr; 1983 Jun; 95(12):424-8. PubMed ID: 6613140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular architecture as a diagnostic marker for differentiation of World Health Organization thymoma subtypes and thymic carcinoma.
    Pfister F; Hussain H; Belharazem D; Busch S; Simon-Keller K; Becker D; Pfister E; Rieker R; Ströbel P; Marx A
    Histopathology; 2017 Apr; 70(5):693-703. PubMed ID: 27791295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymic carcinoma arising in thymoma is associated with alterations in immunohistochemical profile.
    Kuo TT; Chan JK
    Am J Surg Pathol; 1998 Dec; 22(12):1474-81. PubMed ID: 9850173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment, characterization and drug sensitivity testing in primary cultures of human thymoma and thymic carcinoma.
    Ehemann V; Kern MA; Breinig M; Schnabel PA; Gunawan B; Schulten HJ; Schlaeger C; Radlwimmer B; Steger CM; Dienemann H; Lichter P; Schirmacher P; Rieker RJ
    Int J Cancer; 2008 Jun; 122(12):2719-25. PubMed ID: 18360827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Argyrophilic nucleolar organizer regions in cells of thymoma and thymic carcinoma: correlation with DNA ploidy and clinicopathologic characteristics.
    Lee YC; Chern JH; Pan CC; Chang SC; Perng RP
    Chest; 1999 Apr; 115(4):1115-9. PubMed ID: 10208217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desmoglein 3 and p40 immunoreactivity in neoplastic and nonneoplastic thymus: a potential adjunct to help resolve selected diagnostic and staging problems.
    Walts AE; Hiroshima K; Marchevsky AM
    Ann Diagn Pathol; 2015 Aug; 19(4):216-20. PubMed ID: 25979154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinicopathologic analysis of 52 cases of thymic epithelial tumor].
    Ma YQ; Miao N; Abulajiang G; Li QX; Liu X; Zhang W; Wang CF; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):249-54. PubMed ID: 20654124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utility of [18F]-fluorodeoxyglucose positron emission tomography-computed tomography in thymic epithelial tumours.
    Fukumoto K; Taniguchi T; Ishikawa Y; Kawaguchi K; Fukui T; Kato K; Matsuo K; Yokoi K
    Eur J Cardiothorac Surg; 2012 Dec; 42(6):e152-6. PubMed ID: 23024234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow and image cytometry in thymic neoplasia: correlation with clinical outcome.
    Kenny-Moynihan MB; DeRose PB; Gal AA; Chakraborty H; Cohen C
    Anal Quant Cytol Histol; 2001 Aug; 23(4):313-20. PubMed ID: 11531146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.